FN3KRP Human

Fructosamine 3 Kinase Related Protein Human Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Role in Deglycation

FN3KRP phosphorylates non-enzymatic glycation adducts, differing from FN3K in substrate specificity:

  • FN3K: Targets fructosamines (e.g., D-fructoselysine) .

  • FN3KRP: Phosphorylates psicosamines and ribulosamines, expanding the scope of deglycation .

This dual enzymatic system mitigates advanced glycation end products (AGEs), which accumulate in diabetes and aging .

Genetic and Longevity Associations

FN3KRP has emerged as a candidate longevity gene:

  • rs1046896: A 3’UTR variant linked to longevity in German cohorts. The CC genotype (protective allele) correlates with increased FN3KRP expression in blood and tissues .

  • Gene-Based Analysis: Multiple SNVs (e.g., rs138953335, rs61743692) contribute to the longevity signal, suggesting cumulative genetic effects .

Key Genetic Findings

GeneSNVs TestedP-skato (Significance)Association
FN3KRP59.19E−06Longevity
PGP32.50E−06Longevity
CDKN2B-AS1--Validated longevity locus

Data derived from exome-wide association studies .

Research and Therapeutic Implications

  • Aging and Metabolic Diseases: FN3KRP overexpression may protect against glycation-driven arterial stiffening and protein dysfunction .

  • Diabetes: Linked to glycated hemoglobin (HbA1c) regulation; rs1046896-T is a risk allele for HbA1c elevation .

  • Epistatic Interactions: FN3KRP rs1046896 interacts with HMHA1 rs2074442 (immune response gene) and SET9 rs4097 (epigenetic regulator), suggesting complex genetic networks .

Experimental Applications

FN3KRP is used in:

  • Protein Deglycation Studies: Recombinant enzymes for in vitro phosphorylation assays .

  • Longevity Biomarker Research: Expression profiling in centenarians vs. younger controls .

Product Specs

Introduction
Ketosamine-3-kinase (FN3KRP), in contrast to its closely related counterpart fructosamine-3-kinase, exhibits distinct substrate specificity by catalyzing the phosphorylation of psicosamines and ribulosamines. Both enzymes potentially contribute to protein deglycation, restoring protein function. Notably, elevated glucose levels can lead to non-enzymatic protein oxidation through the interaction of glucose with lysine residues (glycation). This glycation process can impair protein activity and functionality.
Description
Recombinant human FN3KRP, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 332 amino acids (residues 1-309) with a molecular weight of 36.8 kDa. This protein features a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution, free from particulate matter.
Formulation
FN3KRP protein is supplied as a 1 mg/ml solution in 20mM Tris-HCl buffer (pH 8.0), containing 0.4M urea and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended periods, store frozen at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity is determined to be greater than 90.0% via SDS-PAGE analysis.
Synonyms
Ketosamine-3-kinase, Fructosamine-3-kinase-related protein, FN3K-RP, FN3K-related protein, FN3KRP, FN3KL.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMEELLRR ELGCSSVRAT GHSGGGCISQ GRSYDTDQGR VFVKVNPKAE ARRMFEGEMA SLTAILKTNT VKVPKPIKVL DAPGGGSVLV MEHMDMRHLS SHAAKLGAQL ADLHLDNKKL GEMRLKEAGT VGRGGGQEER PFVARFGFDV VTCCGYLPQV
NDWQEDWVVF YARQRIQPQM DMVEKESGDR EALQLWSALQ LKIPDLFRDL EIIPALLHGD LWGGNVAEDS SGPVIFDPAS FYGHSEYELA IAGMFGGFSS SFYSAYHGKI PKAPGFEKRL QLYQLFHYLN HWNHFGSGYR GSSLNIMRNL VK.

Q&A

What is FN3KRP and what is its primary function?

FN3KRP (fructosamine-3-kinase-related protein) is a repair enzyme that catalyzes the phosphorylation of psicosamines and ribulosamines on proteins. It plays a crucial role in protein deglycation, which is the reversal of non-enzymatic glycation of proteins. This process helps restore the function of proteins that have been modified by reaction with glucose and other reducing sugars, which can otherwise impair their activity and functionality . FN3KRP is part of a conserved family of repair enzymes present across the Tree of Life and shares detectable sequence similarity to eukaryotic protein kinases .

How does FN3KRP differ from FN3K?

While FN3KRP and FN3K (fructosamine-3-kinase) are highly similar enzymes encoded by neighboring genes, they exhibit different substrate specificities. Both enzymes contribute to deglycation processes, but FN3KRP preferentially phosphorylates psicosamines and ribulosamines, whereas FN3K has different target substrates. Despite these differences, both enzymes work toward the common goal of restoring protein function by reversing glycation damage .

What is the genomic location and structure of the FN3KRP gene?

The human FN3KRP gene is located on chromosome 17, specifically at position 17:80676808-80676926. The gene is also known by aliases including FLJ12171 and FN3KL. Alternative splicing of this gene results in multiple transcript variants . The gene (Entrez Gene ID: 79672) is organized into exonic regions, with validated PCR amplicons spanning these regions to facilitate expression analysis .

What validated methods exist for quantifying FN3KRP expression in human samples?

Quantitative PCR (qPCR) using SYBR Green technology is a validated approach for measuring FN3KRP expression. According to Bio-Rad's PrimePCR assay validation data, primers targeting an 89bp amplicon within the exonic region of FN3KRP achieve 95% efficiency with high specificity (100%) . The assay demonstrates excellent performance metrics with an R² value of 0.9986 and a cDNA Cq value of 22.19, indicating reliable quantification across a wide dynamic range . When performing gene expression analysis, this design approach helps limit potential unwanted signal from contaminating genomic DNA.

What expression systems are suitable for producing recombinant FN3KRP for functional studies?

HEK293T cells have been successfully used for transient overexpression of FN3KRP. The protein can be tagged with C-Myc/DDK epitopes for detection and purification purposes . The transfection protocol typically involves using 5μg of ORF cDNA plasmid with appropriate transfection reagents, with cells being cultured for 48 hours post-transfection before collection. For protein extraction, modified RIPA buffer (25mM Tris-HCl pH7.6, 150mM NaCl, 1% NP-40, 1mM EDTA, proteinase inhibitor cocktail, 1mM PMSF, and 1mM Na3VO4) has been effectively used .

How can researchers develop effective CRISPR knockout models for FN3KRP studies?

CRISPR Knock-Out (KO) HepG2 cell lines have proven valuable for studying FN3KRP function . When developing such models, researchers should consider:

  • Targeting specific exons that are critical for protein function

  • Designing guide RNAs with high specificity and minimal off-target effects

  • Validating knockout efficiency through protein expression analysis

  • Conducting comprehensive phenotypic characterization using multi-omics approaches (transcriptomics, metabolomics, and interactomics) to fully understand the impact of FN3KRP deletion

What genetic evidence links FN3KRP to human longevity?

An exome-wide association study investigating 62,488 common and rare coding variants in 1,248 German long-lived individuals (including 599 centenarians) and 6,941 younger controls identified a significant association between the SNP rs1046896 in FN3KRP and longevity . This association reached exome-wide significance, positioning FN3KRP as a potential longevity gene. Importantly, the longevity-associated allele C of rs1046896 was linked to increased FN3KRP expression in whole blood, with database analyses confirming this effect across various human tissues .

What statistical approaches are recommended for analyzing FN3KRP variants in longevity cohorts?

Based on successful approaches in the literature, researchers investigating FN3KRP's role in longevity should consider a dual analytical strategy:

  • Single-variant analysis: Examining individual SNPs for direct associations with longevity phenotypes, as was successful in identifying the rs1046896 variant

  • Gene-based analysis: Considering cumulative effects of common and rare variants within FN3KRP, which can reveal collective genetic influences that might not be detected through single-variant approaches

When conducting replication studies, researchers should be aware that validation may be context-dependent, as evidenced by the successful replication of CDKN2B-AS1 findings but not FN3KRP findings in a French longevity cohort .

How might FN3KRP's biochemical function contribute to longevity mechanisms?

FN3KRP may influence longevity through its role in metabolic processes, specifically the reverse glycation of proteins . Glycation, particularly in contexts of elevated glucose levels, can progressively impair protein function by modifying lysine residues. By catalyzing the phosphorylation of glycated proteins, FN3KRP may contribute to maintaining protein homeostasis throughout the lifespan, potentially preventing the accumulation of dysfunctional proteins that could otherwise accelerate aging processes .

What cellular pathways are enriched in FN3KRP functional networks?

Integrative multi-omics analyses have revealed that FN3KRP is associated with several key cellular pathways:

  • Oxidative stress response mechanisms

  • Lipid biosynthesis pathways (particularly cholesterol and fatty acid metabolism)

  • Carbon metabolism

  • Co-factor metabolism

These findings suggest FN3KRP has broader metabolic implications beyond its direct enzymatic function, potentially influencing multiple cellular processes relevant to aging and metabolic health .

What is the relationship between FN3KRP and NAD metabolism?

Recent research has uncovered intriguing connections between FN3KRP and NAD-mediated processes:

  • Enrichment of nicotinamide adenine dinucleotide (NAD) binding proteins in FN3KRP interactome studies

  • Localization of human FN3K to mitochondria

  • Specific binding of human FN3K to NAD compounds in a metal and concentration-dependent manner

These findings suggest potential roles for FN3KRP in NAD-mediated energy metabolism and redox balance, which are critical processes in cellular health and aging .

How does FN3KRP respond to different chemical exposures?

FN3KRP expression and function can be modulated by various chemical compounds:

CompoundEffect on FN3KRPExperimental SystemEvidence
Schisandrin BInhibits reactionRat modelCarbon Tetrachloride results in decreased expression of FN3KRP mRNA
2,2',5,5'-tetrachlorobiphenylIncreases expressionRat modelExperimental evidence
Bisphenol SIncreases expressionHuman (ISO)Results in increased expression of FN3KRP protein
Acrolein with methacrylaldehyde, alpha-pinene and OzoneIncreases oxidationHuman (ISO)Results in increased oxidation of FN3KRP mRNA
Actinomycin D with nutlin 3Increases expression and secretionHuman (ISO)Results in increased expression and secretion of FN3KRP protein

This chemical response profile provides insights into potential environmental modulators of FN3KRP activity relevant to research design and interpretation .

What multi-omics approaches are recommended for comprehensive FN3KRP functional characterization?

For thorough characterization of FN3KRP's biological roles, researchers should consider an integrated multi-omics approach combining:

  • Transcriptomics: To identify genes and pathways affected by FN3KRP modulation

  • Metabolomics: To detect metabolic shifts resulting from altered FN3KRP activity

  • Interactomics: To map protein-protein interactions and identify binding partners

This integrated approach has successfully revealed connections between FN3KRP and pathways related to oxidative stress response, lipid biosynthesis, and carbon metabolism that would not be apparent through single-omics approaches .

How can researchers effectively model FN3KRP binding interactions with NAD compounds?

To investigate FN3KRP binding with NAD compounds, researchers should employ a combined computational and experimental approach:

  • Structural modeling to predict binding interfaces and key interaction residues

  • Site-directed mutagenesis of predicted critical residues

  • Binding assays under varying metal ion concentrations, as FN3KRP-NAD interactions show metal dependency

  • Concentration-dependent binding studies to determine affinity constants

This strategy has proven effective in providing insights into the binding modes between human FN3K and NAD compounds .

What are the research implications of FN3KRP's potential role in mitochondrial function?

The localization of human FN3K to mitochondria suggests several important research directions:

  • Investigation of FN3KRP's impact on mitochondrial energy production

  • Examination of potential protective effects against mitochondrial protein glycation

  • Analysis of FN3KRP's role in mitochondrial redox balance

  • Assessment of interactions with NAD-dependent mitochondrial processes, including sirtuin activity

These research directions are particularly relevant for understanding FN3KRP's potential therapeutic applications in diabetic complications and metabolic disorders where redox balance and NAD-dependent metabolic processes are altered .

What are the most promising therapeutic applications for targeting FN3KRP?

Based on current understanding, FN3KRP presents potential therapeutic targets for:

  • Diabetic complications, where protein glycation plays a significant pathophysiological role

  • Metabolic disorders with altered redox balance

  • Age-related conditions where protein damage accumulation contributes to declining function

Targeting FN3KRP activity or expression could potentially enhance cellular repair mechanisms and maintain protein homeostasis in these conditions .

What methodological advances would accelerate FN3KRP research?

To advance FN3KRP research, development of the following methodologies would be valuable:

  • High-throughput screening assays for identifying FN3KRP modulators

  • Improved tissue-specific knockout models to assess context-dependent functions

  • Advanced imaging techniques to visualize FN3KRP activity in real-time within living cells

  • Sensitive methods for detecting and quantifying protein glycation and deglycation events in complex biological samples

How might variations in FN3KRP expression explain contradictory research findings?

When encountering contradictory findings in FN3KRP research, researchers should consider:

  • Tissue-specific expression patterns of FN3KRP

  • Genetic background effects on FN3KRP function

  • Environmental and metabolic context dependencies

  • Methodological differences in detecting FN3KRP activity or expression

  • Potential compensatory mechanisms from related enzymes like FN3K

These considerations are particularly important when translating findings between different model systems or populations.

Product Science Overview

Gene and Protein Structure

FN3KRP is encoded by the FN3KRP gene. This gene is located on chromosome 17 in humans and is closely related to the fructosamine-3-kinase (FN3K) gene. While FN3K specifically targets fructosamines, FN3KRP has a broader substrate specificity, targeting psicosamines and ribulosamines . The protein consists of 309 amino acids and has a molecular mass of approximately 36 kDa .

Function and Mechanism

The primary function of FN3KRP is to catalyze the phosphorylation of glycated proteins. This phosphorylation leads to the formation of unstable intermediates, which subsequently decompose under physiological conditions, effectively removing the glycated residues from the proteins . This process is essential for maintaining protein function and preventing the accumulation of glycated proteins, which can be detrimental to cellular functions.

Clinical Significance

FN3KRP’s role in deglycation has significant implications for conditions such as diabetes, where high blood glucose levels lead to increased protein glycation. By removing glycated residues, FN3KRP may help mitigate some of the complications associated with diabetes . Research is ongoing to explore the potential therapeutic applications of FN3KRP in managing diabetic complications and other conditions involving protein glycation.

Recombinant Production

Recombinant human FN3KRP is produced using Escherichia coli (E. coli) expression systems. The recombinant protein is typically purified to high levels of purity, often exceeding 90%, and is used in various research applications . The recombinant form is also tagged with a His-tag to facilitate purification and detection .

Research and Applications

FN3KRP is a subject of extensive research due to its role in protein deglycation. Studies are focused on understanding its mechanism of action, substrate specificity, and potential therapeutic applications. The recombinant form of FN3KRP is used in various assays to study its activity and interactions with other proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.